JOINT DEVELOPMENT AND LICENSING AGREEMENTJoint Development and Licensing Agreement • August 2nd, 2006 • Illumina Inc • Laboratory analytical instruments • New York
This JOINT DEVELOPMENT AND LICENSING AGREEMENT (this “Development Agreement”) is made effective as of the 15th day of May, 2006 (the “Effective Date”) by and among ILLUMINA, INC., a Delaware corporation having its principal place of business at 9885 Towne Centre Drive, San Diego, California, 92121, including its subsidiary CyVera Corporation, having a place of business at 50 Barnes Park North, Wallingford, CT 06492 (hereinafter collectively referred to as “Illumina”), and DECODE GENETICS, EHF., a limited liability company having its principal place of business at Sturlugata 8, Reykjavik, Iceland (“deCODE”). Illumina and deCODE are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties.” Defined terms have the respective meanings set forth in Section 1 hereof.
JOINT DEVELOPMENT AND LICENSING AGREEMENT FOR INHALED ZAFIRLUKASTJoint Development and Licensing Agreement • July 27th, 2015
− Hovione Scientia Limited committing to a cost-profit sharing co-development and licensing partnership with Invion to develop and manufacture inhaled INV104 using Hovione’s proprietary inhaler
SECTION ONE BACKGROUNDJoint Development and Licensing Agreement • October 17th, 1996 • Coral Systems Inc • California
